Marc A. Loev

National Spine & Pain Centers Holdings LLC operates pain management hospitals. The company was founded by Marc Loev and Les A. Zuckerman in 1998 is headquartered in Rockville, MD.

American Society of Anesthesiologists provides access to multiple choice questions and corresponding discussions to earn CME credits. The private company is based in Park Ridge, IL, and the CEO of the company is Paul Pomerantz. The company offers top jobs in anesthesiology and publish the highest-impact, peer-reviewed medical journal that publishes trusted evidence that transforms the practice of perioperative, critical care, and pain medicine. The company also offers clinical reviews, editorials, podcasts, infographics, and videos.

Vapogenix, Inc. operates as a clinical stage company which develops a new class of non-narcotic analgesics for localized pain. Its products are formulated volatile anesthetics; currently unformulated volatile anesthetics are used only as general anesthetics, by inhalation. The company was founded by Allen W. Burton, Phillip C. Phan and Danguole Spakevicius Altman in November 2007 and is headquartered in Houston, TX.

CarePredict, Inc. offers wearable tech for seniors. It provides Tempo, a wrist-worn sensor that identifies and monitors a senior?s activities of daily living, as well as helps senior living staff and home care providers to identify the changes in daily activities that are precursors to serious health concerns. The company was founded by Satish Movva and Krishna Vedala in 2013 and is headquartered in Plantation, FL.

Part of Curonix LLC, Stimwave Technologies, Inc. is a privately held medical device company based in Pompano Beach, FL. Stimwave specializes in the development, manufacture, and commercialization of wirelessly powered, injectable, microtechnology neurostimulators. These miniature neurostimulators offer patients a convenient, safe, minimally invasive, and cost-effective solution for pain management. The company's goal is to become the leading provider of neuromodulation technology, making it more accessible to patients globally and reducing the economic burden of pain management. Stimwave's FDA-cleared product portfolio includes peripheral nerve stimulation (PNS) and spinal cord stimulation (SCS) products that provide a drug-free alternative for treating chronic pain by blocking pain signals to the brain. The CEO of the company is Aure Bruneau. Stimwave operates worldwide through its operating subsidiaries and was acquired by Curonix LLC on November 01, 2022.